Back to Emergency Medicine
Emergency Medicinev1997Evidence-Based

PSI/PORT Score: Pneumonia Severity Index for CAP

Estimates mortality for adult patients with community-acquired pneumonia (CAP) and guides hospitalization decisions. This extensively validated clinical prediction rule uses demographics, comorbidities, physical examination findings, and laboratory results to stratify patients into risk classes. The score helps determine appropriate care settings and treatment intensity based on mortality risk assessment.

Clinical Input Parameters

years
Range: 18 — 120 years
breaths/min
Range: 5 — 60 breaths/min
mmHg
Range: 50 — 250 mmHg
°C
Range: 30 — 45 °C
bpm
Range: 30 — 200 bpm
pH units
Range: 6.5 — 8 pH units
mg/dL
Range: 1 — 200 mg/dL
mmol/L
Range: 100 — 170 mmol/L
mg/dL
Range: 30 — 800 mg/dL
%
Range: 10 — 70 %
mmHg
Range: 20 — 200 mmHg
Clinical Assessment
Awaiting Parameters
psi score
—points
Ready to Calculate

Awaiting Clinical Input

Enter the clinical input parameters on the left and click Run Clinical Assessment to evaluate this medical calculator with deterministic clinical scoring.

Open in Web App
Clinical decision support tool for licensed medical practitioners. Confirm independently before prescribing or clinical action.

When & Why to Use

The PSI/PORT Score: Pneumonia Severity Index for CAP is utilized in clinical practice for risk stratification, diagnostic probability estimation, and treatment decision-making within emergency medicine.

Use this tool during initial patient intake, emergency department workup, or bedside assessment when objective clinical scoring is required to guide management or admission decisions.

Clinical Formula & Scoring Logic

Sum of demographic points (age + sex adjustment) + comorbidity points + clinical findings points + laboratory findings points

Clinical Pearls & Practice Notes

  • Most extensively validated pneumonia severity score with over 50,000 patients studied
  • Preferred over CURB-65 in 2019 ATS/IDSA guidelines for community-acquired pneumonia
  • Age contributes absolute value as points (e.g., 65-year-old gets 65 points for age)
  • Female sex provides -10 point adjustment due to lower mortality risk
  • Class I patients are young (<50 years) with no comorbidities or high-risk findings
  • May underestimate severity in young patients with severe pneumonia
  • Does not apply to patients with HIV, immunosuppression, or hospital-acquired pneumonia
  • Laboratory values (pH, PaO2) are optional but improve accuracy when available
  • Originally developed and validated in US and Canadian populations
  • Helps standardize admission decisions and reduce unnecessary hospitalizations
  • Should be used in conjunction with clinical judgment and patient preferences
  • Cost-effective tool for healthcare resource allocation and quality improvement

Evidence & Literature Citations

  1. Fine MJ, Auble TE, Yealy DM, Hanusa BH, Weissfeld LA, Singer DE, et al. A prediction rule to identify low-risk patients with community-acquired pneumonia. N Engl J Med. 1997;336(4):243-50. doi: 10.1056/NEJM199701233360402.
  2. Fine MJ, Hanusa BH, Lave JR, Singer DE, Stone RA, Weissfeld LA, et al. Comparison of a disease-specific and a generic severity of illness measure for patients with community-acquired pneumonia. J Gen Intern Med. 1995;10(7):359-68. doi: 10.1007/BF02599829.
  3. Metlay JP, Waterer GW, Long AC, Anzueto A, Brozek J, Crothers K, et al. Diagnosis and Treatment of Adults with Community-acquired Pneumonia. An Official Clinical Practice Guideline of the American Thoracic Society and Infectious Diseases Society of America. Am J Respir Crit Care Med. 2019;200(7):e45-e67. doi: 10.1164/rccm.201908-1581ST.
  4. Aujesky D, Auble TE, Yealy DM, Stone RA, Obrosky DS, Meehan TP, et al. Prospective comparison of three validated prediction rules for prognosis in community-acquired pneumonia. Am J Med. 2005;118(4):384-92. doi: 10.1016/j.amjmed.2005.01.006.

Score Interpretation Ranges

Class I-II (Low Risk)0 – 70 pts

Low mortality risk

Class III (Low Risk)71 – 90 pts

Low mortality risk

Class IV (Moderate Risk)91 – 130 pts

Moderate mortality risk

Class V (High Risk)131 – 999 pts

High mortality risk

Need Clinical Suite Access?

Run this calculator with patient history, laboratory integration, and drug interaction safety checks on the DexaMed clinician app.

Open in Web App

Clinical Decision Support (CDS) Notice & Legal Disclaimer

This medical calculator and its scoring interpretation are provided strictly for licensed healthcare professionals and medical trainees as an educational and clinical decision support instrument. It does not replace independent clinical judgment, comprehensive patient history, physical examination, or attending physician oversight. Not FDA-cleared as an autonomous diagnostic medical device. Read the full DexaMed Medical Disclaimer.